CalumetCLMT -0.03%50 EBIT per Share is $-1.08 as of Mar. 2026. GuruFocus rates CLMT with a GF Score™ of 50/100 and a GF Value™ of $15.90 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 1,336 Chemicals companies, Calumet ranks worse than 82.71% on this metric.
Calumet's EBIT per Share for the
three
months ended in Mar. 2026 was $-3.30.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $-1.08.
During the past 3 years, the average EBIT per Share Growth Rate was -27.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Calumet's EBIT per Share or its related term are showing as below:
CLMT'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -96.1 Med: -11.1 Max: 96.3
Current: -27.9
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Calumet was 96.30% per year. The lowest was -96.10% per year. And the median was -11.10% per year.
CLMT's 3-Year EBIT Growth Rate is ranked worse than 82.71% of 1336
companies
in the Chemicals industry
Industry Median: -1.15
vs CLMT: -27.90
Calumet's EBIT for the
three
months ended in Mar. 2026 was $-287 Mil.
Calumet (NAS:CLMT) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Calumet EBIT per Share Related Terms
Calumet EBIT per Share Historical Data
* Premium members only.
The historical data trend for Calumet's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.08
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Calumet (CLMT) has a EBIT per Share of $-1.08 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Calumet and its competitors. According to the industry distribution chart, Calumet ranks #1105 out of 1336 companies in the Chemicals industry, placing it in the top 82.7%.
Is Calumet's EBIT per Share too high?
Calumet's current EBIT per Share is $-1.08. Based on the distribution chart, Calumet ranks #1105 out of 1336 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Calumet has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Calumet's EBIT per Share compare to CC and ASH?
According to the Chemicals industry distribution chart, Calumet ranks #1105 out of 1336 companies for EBIT per Share. This places Calumet in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Chemicals company?
A good EBIT per Share depends on the Chemicals industry context. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Calumet and its competitors. Calumet's current EBIT per Share is $-1.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calumet stock overvalued right now?
Based on GuruFocus' analysis, Calumet (CLMT) is currently considered Significantly Overvalued. The stock's GF Value™ is $15.90, compared to a current price of $36.39 — trading 128.9% above its estimated fair value. The current EBIT per Share is $-1.08. Calumet's overall GF Score™ is 50/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Calumet (CLMT), the current EBIT per Share is $-1.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Calumet (CLMT) Overvalued in 2026?
Based on GuruFocus' analysis, Calumet stock appears to be overvalued.
The current stock price of $36.39 is trading 128.9% above its estimated GF Value™ of $15.90.
GuruFocus considers Calumet to be Significantly Overvalued.
Key valuation signals for CLMT:
EBIT per Share: $-1.08
GF Value™: $15.90 vs. price of $36.39 (128.9% above fair value)
No single metric tells the full story. See the CLMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
50GF Score
Get the complete analysis for CLMT
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLMT has been successfully added to your 
